Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
On Feb. 18, 2025, Hologic announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance…
Biotechnology | COVID-19 | Infectious Disease | Influenza | Measles | Polio | Vaccine
Louisiana Surgeon General ignores science, will not promote vaccines
On Feb. 13, 2025, Ralph L. Abraham, MD, the Louisiana Surgeon General announced that the state will no…
Agriculture | Biotechnology | Chemistry | COVID-19 | Diagnostics | Genomics | Infectious Disease | Influenza | Stem Cell | USDA | Vaccine | WHO | Women's Health
trust in scientists is high
On Jan. 20, 2025, a large international 68-country survey of 71,922 respondents found that in most countries, most…
BARDA Awards $375 million to develop COVID-19 pre-exposure prophylaxis
On Jan. 16, 2025, Shionogi Inc. has been awarded a $375 million project agreement through the Rapid Response…
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | Influenza | Therapeutics | Vaccine
U.S. respiratory virus infections rise, led by flu
On Jan. 3, 2025, the Centers for Disease Control and Prevention (CDC) reported that during Christmas week, respiratory…
The effect of nirmatrelvir-ritonavir on short- and long-term adverse outcomes from COVID-19 among patients with kidney disease
On Dec. 31, 2024, a study was published of patients with kidney disease who are at high risk…
BioNTech enters settlement with U.S. agency, UPenn over COVID vaccine royalties
On Dec. 27, 2024, BioNTech announced it had entered into two separate settlement agreements with the U.S. National…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine | WHO
SARS-CoV-2 virus circulates Worldwide without clear seasonality and continues to infect
On Dec. 24, 2024, the World Health Organization (WHO) announced that SARS-CoV-2, the virus that causes COVID-19, largely…
Controversial COVID study that promoted unproven hydroxychloroquine treatment retracted after four-year saga
On Dec. 18, 2024, a study that stoked enthusiasm for the now-disproven idea that the cheap malaria drug…
Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Species resistant to Albendazole/Ivermectin Combination Treatment
On Dec. 18, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported a study with patient…
COVID-19 linked to more heart complications than flu, RSV
On Dec. 16, 2024, a study published in BMC Cardiovascular Disorders shows that pediatric and young adult COVID-19…
A Lipid Nanoparticle Delivered mRNA Cure for Pre-eclampsia
On Dec. 11, 2024, University of Pennsylvania Engineers announced they had made a critical breakthrough that bridges a…
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | NIH | Vaccine
Wuhan lab samples hold no clues relatives to virus behind COVID
On Dec. 6, 2024, Shi Zhengli, the Chinese virologist at centre of COVID lab-leak theory, has presented evidence…
Biotechnology | COVID-19 | HIV | Vaccine
mpox confirmed in two more nations
On Dec. 5, 2024, the World Health Organization (WHO) announced that as of December 1, 20 countries have…
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Influenza | Measles | Polio | Vaccine
COVID-19 Vaccination Coverage Among U.S. Adults reported below 20%
On Nov. 21, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that by the week…
Human Cell Atlas achieved leap in understanding of the human body
On Nov. 20, 2024, researchers with the global Human Cell Atlas (HCA) consortium reported significant progress in their…
Biotechnology | COVID-19 | HIV | Vaccine
WHO added LC16m8 mpox vaccine to Emergency Use Listing
On Nov. 19, 2024, the World Health Organization (WHO) announced it had granted Emergency Use Listing (EUL) to Japan-based…
Before RSV vaccine, virus caused substantial illness in US adults
On Nov. 13, 2024, a study published in JAMA Network Open showed that respiratory syncytial virus (RSV) was…
Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief, studies find
On Nov. 11, 2024, findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to…
Researchers discovered unique genome folding in turtles
On Nov. 11, 2024, a team of researchers led by Iowa State University (ISU) have shown that as…
Nasal Swab Tests Predict COVID-19 Disease Severity, Study Finds
On Nov. 6, 2024, researchers from Emory University, in collaboration with scientists at Gladstone Institutes and University of…
Study revealed stubborn mistrust in COVID-19 vaccine science
On Nov. 4, 2024, a study conducted by researchers from the CUNY Graduate School of Public Health and…
New risks raise pandemic threat on a global scale
On Oct. 14, 2024, the Global Preparedness Monitoring Board (GPMB) released a report that outlined 15 key drivers…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Neurology | NIH | Non-Profit Research | Therapeutics | Vaccine
Study Found Persistent Infection Could Explain Long COVID in Some People
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
Novavax’s Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Received Authorization in the EU
On Oct. 9, 2024, Novavax announced that the European Commission had granted Marketing Authorization for Novavax’s updated 2024-2025…
COVID-19 hospitalization remained higher among older adults
On Oct. 4, 2024, the Centers for Disease Control and Prevention (CDC) published data that showed older adults…
GSK invests up to $800 million in Pennsylvania site
On Oct. 24, 2024, GSK announced an $800 million investment that will bring state-of-the-art drug substance manufacturing and…
MERS coronavirus case reported in Saudi Arabia
On Oct. 2, 2024, the World Health Organization (WHO) announced it had been notified of one human case…
Brain Scans revealed changes from Long COVID Fatigue
On Sept. 27, 2024, a study that evaluated the structural and functional connectivity correlates of fatigue in post-COVID…
COVID-19 Symptoms Reduced Among U.S. Healthcare Personnel Receiving Additional Vaccine Doses
On Sept. 25, 2024, U.S. healthcare workers receiving additional vaccine doses during the Omicron period (December 2021 to…